Resultado de búsqueda
James P. Allison (7 de agosto de 1948) es un inmunólogo estadounidense. Ocupa la cátedra de Inmunología y es el director ejecutivo de la plataforma de inmunoterapia en el M. D. Anderson Cancer Center .
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.
Dr. Allison is a Nobel laureate and a pioneer of immunotherapy for cancer. He is the chair of the Department of Immunology, the director of the Parker Institute for Cancer Immunotherapy, and the executive director of the Allison Institute at MD Anderson Cancer Center.
James Allison is an American immunologist who discovered how to inhibit negative immune regulation and treat cancer. He shared the Nobel Prize with Tasuku Honjo for their groundbreaking work on cancer therapy by immune checkpoint blockade.
1 de oct. de 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
1 de oct. de 2018 · Allison, de 70 años y profesor en la Universidad de Texas, estudió a inicios de los 90 la proteína CTLA-4 que funciona como un freno del lifoncito T, una de las células principales que conforman...
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
